Recombinant Human Erythropoietin Treatment May Improve Quality of Life and Cognitive Function in Chronic Hemodialysis Patients
- 1 December 1989
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 14 (6) , 478-485
- https://doi.org/10.1016/s0272-6386(89)80148-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Electrophysiological indices of CNS function in hemodialysis and CAPDKidney International, 1986
- End-Stage Renal Disease Treatment Modality and Patients’ Quality of LifeAmerican Journal of Nephrology, 1986
- Anemia of end-stage renal disease (ESRD)Kidney International, 1985
- The Quality of Life of Patients with End-Stage Renal DiseaseNew England Journal of Medicine, 1985
- Effects of hemodialysis on the cognitive and sensory-motor functioning of the adult chronic hemodialysis patientJournal of Behavioral Medicine, 1983
- Intellectual functioning in renal failure and chronic dialysisJournal of Chronic Diseases, 1982
- Neuropsychological patterns in uremiaJournal of Clinical Psychology, 1982
- Physical Activity and Employment Status of Patients on Maintenance DialysisNew England Journal of Medicine, 1981
- Quantitative indices of clinical uremiaKidney International, 1979